Schedule 13D ownership disclosure

BIONEXUS GENE LAB CORP

Security class unavailable · CUSIP: 090628207

Event date: 2023-12-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.0250%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001477932-24-000214
Form type
SC 13D
Filer
BioNexus Gene Lab Corp
CIK
CIK 1737523
Filed
Jan 17, 2024
Reporting period
Dec 11, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub